New York City, NY -- (SBWIRE) -- 01/29/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: The Boeing Company (NYSE:BA), Yandex NV (NASDAQ:YNDX), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Sprint Corporation (NYSE:S)
The Boeing Company (NYSE:BA) declined -4.78% recently, while trading on 5.02 million shares, at the price of $130.84. The stock changed hands in a range of $128.07 to $131.76 up till now, bringing its market capitalization at about $98.13 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $73.00 and was moved to the maximum level of $144.57. The Boeing Company (Boeing) is an aerospace company. The Company operates in five segments: Commercial Airplanes, Boeing Military Aircraft (BMA), Network & Space Systems (N&SS), Global Services & Support (GS&S) and Boeing Capital Corporation (BCC).
Has BA Found The Bottom And Ready To Gain Momentum? Find Out Here
Yandex NV (NASDAQ:YNDX) declined -4.83% recently, in the current trading session, at $35.86 with a total volume of 1.83 million shares. The stock, on average, trades on a volume of 2.62 million shares. It floated in a range of $35.28 to $37.01 during the recent trading session. Its market capitalization now moved to about $12.50 billion. In the past 52 weeks, the share price has not declined below $19.93 or above $45.42. Yandex N.V. (Yandex) is an Internet company in Russia. During the year ended December 31, 2011, the Company generated 63.3% of all search traffic in Russia, and 60.6% in December 2011, and its Yandex sites attracted 45 million visitors in December 2011. It also operates in Ukraine, Kazakhstan, Belarus and Turkey.
Why Should Investors Buy YNDX After the Recent Fall? Just Go Here and Find Out
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) recently recorded a gain of 0.15% and was moving within a range of $77.85-$80.00, its current trading price is $79.28. The stock is moving up till now with a total volume of 349,216 shares, versus an average volume of 1.63 million shares. The share price hit its 52-week low of $43.57 and $89.96 was the best price. Vertex Pharmaceuticals Incorporated (Vertex) is in the business of discovering, developing, manufacturing and commercializing small molecule drugs for the treatment of serious diseases. The Company’s two products are INCIVEK (telaprevir), which is approved for the treatment of patients with genotype 1 hepatitis C virus (HCV), infection, and KALYDECO (ivacaftor), which is approved in the United States for the treatment of patients six years of age and older with cystic fibrosis (CF), who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), gene.
For How Long VRTX Gloss will Attract Investors? Find out via this report
Sprint Corporation (NYSE:S) declined -4.40% in its current trading activity, bringing its market capitalization around $34.84 billion. The share price, after opening at $8.53, hit a high of $8.55 and hovered above $8.25, while its recent trading price was $8.46. The total number of shares changed hands during the current session up till now was 7.78 million shares, as compared to average trading volume of 21.96 million shares.
Will Sprint Corporation Get Buyers Even After The Recent Rally? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)